Cornerstone Planning Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cornerstone Planning Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$159	Buy	+5	New	+$159	﹤0.01%	1521

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Cornerstone Planning Group's ARKG Position: Q4 2022 in Review

Cornerstone Planning Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q4 2022: 5 shares worth $159. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings.

319 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Cornerstone Planning Group held 5 shares of ARK Genomic Revolution ETF worth $159 as of Q4 2022.
ARK Genomic Revolution ETF was a new Cornerstone Planning Group position in Q4 2022.
ARK Genomic Revolution ETF made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q4 2022, its #1521 holding.
319 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Cornerstone Planning Group's 13F filing for Q4 2022, filed 14 Feb 2023.